Clinical and histologic predictors of response to interferon-α in patients with chronic hepatitis C viral infection
- 1 December 1994
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 39 (12) , 2660-2664
- https://doi.org/10.1007/bf02087706
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Treatment of chronic hepatitis C with high-dose interferon ?-2bDigestive Diseases and Sciences, 1993
- Phenobarbital Pharmacokinetics in ObesityClinical Pharmacokinetics, 1992
- Therapy of chronic post-transfusion non-A, non-B hepatitis with interferon alfa-2b: Swedish experienceJournal of Hepatology, 1990
- One-year treatment of chronic non-A, non-B hepatitis with interferon alfa-2bJournal of Hepatology, 1990
- A randomized controlled trial of interferon alfa-2b as therapy for chronic non-A, non-B hepatitisJournal of Hepatology, 1990
- Prolonged treatment (18 months) of chronic hepatitis C with recombinant α-interferon in comparison with a control groupJournal of Hepatology, 1990
- Recombinant Interferon Alfa Therapy for Chronic Hepatitis CNew England Journal of Medicine, 1989
- Treatment of Chronic Hepatitis C with Recombinant Interferon AlfaNew England Journal of Medicine, 1989
- Drug Disposition in Obese HumansClinical Pharmacokinetics, 1986
- Sex-Related Differences in Drug Disposition in ManClinical Pharmacokinetics, 1984